Clinical and pharmacological variables as a risk factor for nifedipine-induced gingival overgrowth


GÜNCÜ G. N. , ÇAĞLAYAN F. , Dincel A., Bozkurt A. , ÖZMEN F. , KARABULUT E.

AUSTRALIAN DENTAL JOURNAL, cilt.52, ss.295-299, 2007 (SCI İndekslerine Giren Dergi) identifier identifier

Özet

Background. Gingival enlargement is usually noted within one to two months after the initiation of nifedipine therapy. The aetiology of nifedipine-induced gingival overgrowth is uncertain. The aim of this study was to determine the relationship between plasma and gingival crevice fluid (GCF) nifedipine concentrations and the degree of gingival overgrowth in patients treated with nifedipine, and also to assess the correlations between clinical and pharmacological variables.